ARTICLE | Clinical News
Ad26: Completed Phase I/IIa enrollment
August 8, 2016 7:00 AM UTC
Johnson & Johnson’s Janssen Vaccines & Prevention B.V. unit completed enrollment of about 400 healthy volunteers in a double-blind, placebo-controlled, international Phase I/IIa trial evaluating intra...